February 26, 2015
A $2.5 million verdict was handed down against Janssen Pharmaceuticals for failure to warn that it’s antipsychotic drug Risperdal can cause boys to develop female breasts – a permanent condition known as gynecomastia. The first-in-the-nation verdict was won by Tom Kline of Kline & Specter in…
April 10, 2014
Tom Kline has been named co-liaison counsel by the Court of Common Pleas for Philadelphia for the coordinated litigation involving the drug Risperdal. The anti-psychotic pharmaceutical has been linked to abnormal breast growth in males, including children, adolescents and adults, a condition called…
April 08, 2014
Kline & Specter is a leader in litigation involving the anti-psychotic drug Risperdal, which has been linked to abnormal breast development in male children, adolescents and adults, a condition known as gynecomastia. The ailment, caused by an increase in the hormone prolactin, can often be…